Skip to main content
Premium Trial:

Request an Annual Quote

Genome Technology s Lab Notebook: Reader Tips and Experiences: Jan 20, 2005

Following is a scientist's responses to the question, "What's your top advice for designing a microarray analysis experiment to ensure that your statistical analysis, control for error, and normalization procedures will give you an accurate end answer?"

For a complete list of scientists' responses, read the November/December issue of Genome Technology , a GenomeWeb News sister publication.

"My number one piece of advice is to be absolutely sure that all samples are prepared using the same method. If a subset of samples are limiting, then do all samples using the protocol for the most limiting method. Each sample preparation method has an inherent rate of reproducibility, but it will also have an inherent bias. This bias is typically consistent for all samples prepared by that method. If you use two different methods you will be adding a new, uncontrolled factor to your study which will likely make it more difficult to analyze your results.

"My second piece of advice is don't limit yourself on the number of experimental replicates. You will get better data doing one 6x6 comparison than by doing 3x3x3x3. Let the power of your study work for you."

Chris Barker
Director, Genomics Core Laboratory

Gladstone Institute of Cardiovascular Disease
University of California, San Francisco

The Scan

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."